AbbVie Stock Drops 09% on May 1 2025 with 1126 Billion Trading Volume Ranking 62nd in Market Activity
AbbVie Inc. (ABBV) shares fell 0.90% on May 1, 2025, with a trading volume of 11.26 billion, ranking 62nd in the day's market activity.
On December 6, 2023, Cerevel publicly announced that AbbVieABBV-- agreed to acquire Cerevel for $45 per share. The merger allowed Bain to receive a windfall of more.
Truist Financial raised their price target on shares of AbbVie from $211.00 to $217.00 and gave the company a “buy” rating in a research note on Monday.
Guggenheim Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock. AbbVie (NYSE:ABBV) Given New $216.00 Price Target at Guggenheim.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet